Abstract Ensifer meliloti is a nitrogen-fixing sym-
Introduction
Ensifer meliloti belongs to the group of rhizobia, whose most conspicuous characteristic is the ability to establish symbiotic association with legumes and carry out nitrogen fixation. Rhizobia are normally present in different habitats (e.g. soil, rhizosphere, plant host) where free iron is usually mostly inaccessible due to low solubility, organic binding or immobilization. E. meliloti and many other bacteria possess different high affinity iron acquisition systems that share common traits: are maximally expressed when iron is scarce and, involve the presence of TonBdependent outer membrane receptors and ABC transporters . In E. meliloti strain 1021, these systems include the production and Electronic supplementary material The online version of this article (doi:10.1007/s10534-016-9919-3) contains supplementary material, which is available to authorized users. secretion of the rhizobactin 1021 siderophore, the hijacking of xenosiderophores (ferrichrome and ferrioxamine B) and the acquisition of iron from heme compounds (Cuiv et al. 2008; Noya et al. 1997; Persmark et al. 1993) . For many years, transport and degradation of heme as a mechanism to acquire iron was thought to be exclusive to pathogens. However, our group discovered that rhizobia and other nonpathogenic bacteria can use heme or hemoglobin as iron sources (Noya et al. 1997) . Subsequently, genes involved in heme transport were identified in Bradyrhizobium japonicum, Rhizobium leguminosarum and E. meliloti (Amarelle et al. 2008; Battistoni et al. 2002; Nienaber et al. 2001; Wexler et al. 2001) . Notably, while the use of xenosiderophores was found to be a variable trait, heme transport systems are present in all the rhizobia strains studied so far. Moreover, rhizobia heme transport systems are present in the chromosome and not in plasmids, suggesting its importance for the metabolism of these bacteria .
The outer membrane heme-receptor involved in the internalization of heme, hemoglobin and leghemoglobin in E. meliloti is ShmR (Amarelle et al. 2008; Battistoni et al. 2002) and HmuTUV is the ABC transporter required, among other functions, for heme uptake (Cuiv et al. 2008) . Expression of the E. meliloti shmR gene under iron limitation involves the loss of the repression exerted by RirA (Rhizobial iron regulator) (Chao et al. 2005; Viguier et al. 2005) as well as the activation mediated by the HmuP protein (Amarelle et al. 2010) . RirA is the primary iron-responsive transcriptional regulator in E. meliloti, while the Fur homolog, renamed as Mur, is mainly involved in the control of manganese homeostasis (Chao et al. 2005; Diaz-Mireles et al. 2004; Platero et al. 2004 ). The fate of exogenous heme once inside E. meliloti cytosol is unknown.
Different enzymes and mechanisms allowing iron release from heme have been described in bacteria (Benson and Rivera 2013; Wilks and Ikeda-Saito 2014) . In Corynebacterium diphtheria, the pioneering work of Schmitt (1997) and Wilks and Schmitt (1998) demonstrated that once heme is taken up by bacterial cell, the tetrapyrrole ring is cleaved by heme oxygenases (HOs) in order to release iron. HOs are ubiquitous enzymes that degrade heme to biliverdin IX-a, iron and carbon monoxide, using O 2 and a reductant such as NADPH cytochrome P450 reductase for oxidation (Benson and Rivera 2013; Montellano 2000) . Bacterial heme oxygenases have limited sequence similarity to each other but are structurally and mechanistically similar to those of the eukaryotic HO (Hirotsu et al. 2004; Schuller et al. 1999 Schuller et al. , 2001 Wilks and Ikeda-Saito 2014) .
A novel class of heme-degrading enzyme, IsdG (Iron-regulated surface determinant) structurally unrelated to canonical HOs, was discovered in Staphylococcus aureus (Reniere et al. 2010; Skaar et al. 2004; Wu et al. 2005) . Homologous to this heme-degrading enzyme, which belongs to the group of the antibiotic biosynthesis monooxygenase family (ABM), were also found in a limited number of gram-positive and gram-negative bacteria (Ojeda et al. 2012; Park et al. 2014; Puri and O'Brian 2006; Skaar et al. 2006) . Interestingly, some members of this group of enzymes such as IsdG and IsdI of S. aureus and HmoB of Bacillus subtilis, catalize the degradation of heme to staphylobilins (15-oxo bilirubin IX-b and 5-oxobilirubin IX-d) and formaldehyde rather than to biliverdin and CO Park et al. 2014; Reniere et al. 2010) . In Mycobacterium tuberculosis, the IsdG homolog named MhuD, catalyzes heme degradation producing a novel heme catabolite, mycobilin, without the release of CO or formaldehyde, and retaining the meso-carbon of the porphyrin ring as an aldehyde ). In B. japonicum, two heme-degrading enzymes belonging to the ABM group of enzymes, HmuQ and HmuD, have been described. HmuQ has weak homology with S. aureus IsdG, being biliverdin the heme degradation product (Puri and O'Brian 2006) .
The hemS (or hmuS) gene is annotated as a ''heme degrading enzyme'' in the genome databases although this activity has been demonstrated only for few bacteria. Particularly, this activity has been reported for ChuS in Escherichia coli and PhuS in Pseudomonas aeruginosa (Lee et al. 2014; Suits et al. 2005) . The crystal structure of ChuS from E. coli O157:H7 has been characterized and presents a different folding structure than that of known mammalian and bacterial HOs (Suits et al. 2005) . Additionally, iron release from heme without tetrapyrrole ring disruption was found in E. coli (Letoffe et al. 2009; Turlin et al. 2014) .
HO function has been associated with cellular signaling, antioxidant defense and biosynthesis of light-sensing bilins. HO also participates in the use of heme as nutritional iron source in numerous bacteria (Benson and Rivera 2013; Frankenberg-Dinkel 2004) .
Here we report the identification and characterization of two enzymes from E. meliloti 1021 with heme degrading activity in vitro: HmuQ and HmuS. We demonstrate that both proteins bind heme, are capable of degrading this compound and produce biliverdin. Moreover we demonstrate that humQ and hmuS gene expression is regulated by iron and heme, and that both proteins are involved in heme metabolism in E. meliloti in vivo.
Materials and methods

Bacteria, plasmids and growth conditions
Bacteria and plasmids used in this study are listed in Table 1 . E. coli strains were grown aerobically at 37°C in Luria-Bertani (LB) medium or 2xYT medium (Sambrook et al. 1989 ). E. meliloti strains were grown at 30°C in tryptone-yeast extract medium (TY) (Beringer 1974) , defined minimal medium M9 (Sambrook et al. 1989 ) supplemented with 6 mM glutamate, 200 lM methionine and 1 lM biotin (M9S) or LB medium supplemented with 2.5 mM MgSO 4 and 2.5 mM CaCl 2 (LBMC). Low iron conditions were obtained by supplementation with ethylenediamine-dio-hydroxyphenylacetic acid (EDDHA) and high iron conditions were obtained by adding FeCl 3 to the media. The micromolar concentrations of FeCl 3 , EDDHA (abbreviated as E) and hemin (Hm) used for each assay are indicated with subscripts When required, 50 lg/ml kanamycin (Km), 100 lg/ml neomycin (Nm), 100 lg/ ml streptomycin (Sm), 10 lg/ml gentamycin (Gm) (for E. coli), 5 lg/ml gentamycin (for E. meliloti), 50 lg/ml ampicillin (Ap) or 25 lg/ml cloramphenicol (Cm) were added to the media.
Construction of Sm1021-VAQ and Sm1021-VAS mutants
To generate an hmuQ mutant (Sm1021-VAQ), a 2350 bp DNA fragment containing the hmuQ gene and flanking regions was amplified from E. meliloti 1021 genome using primers 5-CGTAACCCCAAAAC-GAACCTGTCC-3 and 5-CACCGTGGAAGTGTCGC TGCT-3. The fragment obtained was digested with PstI/ XhoI and cloned in pBlueScriptSK (pSK) (Stratagene) obtaining plasmid pSKhmuQ. To interrupt the hmuQ gene, the lacZ-Gm r cassette of pAB2001 (Becker et al. 1995) was cloned in the EcoRI site of pSKhmuQ generating pSKhmuQ::lacZ-Gm r . Cloning in the correct orientation was confirmed by restriction mapping. The hmuQ::lacZ-Gm r fragment was sub-cloned in the BamHI site of pK18mobSacB (pK18) (Schafer et al. 1994 ) obtaining plasmid pK18hmuQ::lacZ-Gm r which was then mobilized into E. meliloti 1021 by triparental mating using DH5a-pRK2013 (Figurski and Helinski 1979) as a helper strain. Colonies Sm r , Gm r and able to grow in 15 % (w/v) sucrose (Suc r ) were selected and the mutation was confirmed by Southern blot hybridization.
To obtain an hmuS mutant (Sm1021-VAS), a 2054 bp DNA fragment containing the hmuS gene and flanking regions was amplified from E. meliloti 1021 genome using primers 5-ATAGGATCCACGA AGGTCAACTTGCA-3 and 5-TCTGGATCCAAGG-GAATGTTCGCCTC-3. BamHI restrictions sites are underlined. The amplicon was cloned at the EcoRV site of pSK obtaining plasmid pSKhmuS. An in-frame deletion of hmuS gene was done by inverse PCR using primers 5-ATAGATATCGGTGGGGCGAATGCT-3 and 5-ATAGATATCGTCGCGGCCTGATGGTG-3 and pSKhmuS as template. EcoRV restriction sites are underlined. PCR product was digested with EcoRV and autoligated in order to obtain plasmid pSKhmuSif. The hmuS deleted gene was cloned in the BamHI site of pK18 in order to generate plasmid pK18hmuSif which was then mobilized into E. meliloti 1021 and Sm1021-VAQ strains by triparental mating as previously described, in order to generate Sm1021-VAS mutant and Sm1021-VAQS double mutant, respectively. Sm r and Suc r colonies were selected and the mutations were confirmed by PCR.
In order to have the hmuQ and hmuS genes mutated in a background where no endogenous siderophore is produced, mutation in the rhrA gene of strain Sm1021-H38 (Platero et al. 2003) was transduced with phage AM12 (Finan et al. 1984) to the Sm1021-VAQ, Sm1021-VAS and Sm1021-VAQS mutant strains. Transductions were done as previously described (Finan et al. 1984) . Briefly, AM12 lysates of Sm1021-H38 mutant were generated by growing Sm1021-H38 in LBMC, culture diluted to an OD 600nm of 0.3-0.4 in LBMC was incubated with AM12 at 30°C until complete lysis occur. Lysates were filtered and diluted in order to infect Sm1021-VAQ, Sm1021-VAS and Sm1021-VAQS cells previously grown in ColE1 replicon with RK2 tra genes. Used for mobilizing incP and incQ plasmids (Km r ) (Ditta et al. 1980) pK18mobSacB Broad host range mobilizable vector. Non replicative in E. meliloti, sacB, oriV (Km r ) (Schafer et al. 1994) pSKhmuQ pBlueScript SK containing hmuQ coding sequence (Ap LBMC to an OD 600nm of 0.8. Infection was carried on for 20 min, cells were immediately washed twice with TY and plated on TY supplemented with Sm and Nm. Transductants were re-streaked twice in order to avoid phage contamination.
With the aim to obtain the hmuQ gene mutated in a background where the global iron regulator RirA is not present, the hmuQ mutation of Sm1021-VAQ strain was transduced with phage AM12 to the rirA mutant strain. Transduction was performed as above-mentioned and Sm r and Gm r colonies were selected.
Growth assays
For colony size experiments, appropriate dilutions of mid-exponential (OD 620nm of 0. i. RNA purification and real-time qPCR. Expression of hmuQ and hmuS genes was assessed by quantitative real-time PCR (qPCR). For RNA isolation, mid-exponential phase cultures of E. meliloti 1021 grown in M9S supplemented with 300 lM EDDHA, 300 lM EDDHA and 1 lM Hm, 300 lM EDDHA and 20 lM Hm or 37 lM FeCl 3 were used. RNA purification was performed as described elsewhere (Amarelle et al. 2010 ). Reverse transcription was carried out with total RNA using the iScript cDNA Synthesis Kit (Bio-Rad).
Conditions used for real-time PCR were as mentioned elsewhere (Amarelle et al. 2010) . Primers used for hmuQ quantification were 5-TAC TTCGCCATGAACCGTTTCCGT-3 and 5-CGC AGCAGATGGAATTCGATGAAG-3 and for hmuS quantification were 5-AATGGCGGCGT-CATCCAGATTCAT-3 and 5-GCAGATGCA-GATGGAAGGTTTCGT-3. The generation of specific PCR products was confirmed by melting curve analysis. Gene smc03224, a 16S rDNA, was used as a control using primers 5-GTGTCTCAGT CCCAATGT-3 and 5-TCTACGGAATAACG-CAGG-3 previously described (Dominguez-Ferreras et al. 2006) . Reactions without reverse transcriptase addition were used as negative controls. For relative quantification, the standard curve method was performed using E. meliloti 1021 genomic DNA as PCR template. The data are expressed as the relative starting quantities (SQ) of mRNA normalized to smc03224 and presented as the average from three independent determinations. ii. B-galactosidase transcriptional fusion. The transcriptional fusion with the promoterless cassette lacZ-Gm r , generated as a result of Sm1021-VAQ mutant construction, was used also in the case of hmuQ gene expression. b-galactosidase activity was assessed in the Sm1021-VAQ mutant and in rirA/hmuQ double mutant. E. meliloti 1021 parental strain and rirA mutant strain were used as controls. Mid-exponential phase cultures grown in M9S medium were diluted 100-fold in M9S medium supplemented with either 37 lM FeCl 3 , 300 lM EDDHA, 300 lM EDDHA plus 1 lM Hm or 300 lM EDDHA plus 20 lM Hm. Mid-exponential phase cultures were used for bgalactosidase assay, performed according to the kinetic protocol described by Thibodeau et al. (Thibodeau et al. 2004) . Briefly, cells were lysed with 1 % (v/v) triton X-100, 1 % (w/v) Sarkosyl and 1 mg/ml of lysozyme for 15 min at room temperature. An aliquot of 40 ll was transfer to a Nunc F-bottom 96 well plate and 130 ll of Z buffer (Miller 1972 ) with 0.27 % (v/v) b-mercaptoethanol was added, and the plate was loaded in a Varioskan Flash Ò (Thermo) for substrate dispensing. Plate was incubated 10 min at 30°C, 30 ll of 4 mg/ml o-Nitrophenyl b-D-galactopyranoside (ONPG) in Z buffer was added to each well, and the absorbance at 420 nm was recorded every 2 min over a period of one hour. The maximum rate (DAbs/Dmin) was measured and the enzymatic activity, expressed as nmoles of o-Nitrophenol produced per min per optical density at 620 nm per ml, was determined. Each experiment was performed independently three times. iii. GFP-UV promoter fusion. In order to evaluate the activity of the promoter region corresponding to hmuS gene, a plasmid-borne transcriptional fusion with gfp-UV was constructed. For this purpose, a 464 bp DNA fragment containing hmuPSTUV promoter region was amplified from E. meliloti 1021 genome by PCR using primers 5-GGCCTTTCTGATCGAAGAGCACG-3 and 5-CAGCGGCGCCACGGTTTG-3. The amplicon was cloned at the EcoRV site of pBSK generating plasmid pSK-prhmuS. Correct orientation was confirmed by restriction mapping. A HindIII-XbaI fragment was subcloned in plasmid pOT1 (Allaway et al. 2001 ) generating plasmid pOTprhmuS. Plasmid pOT-prhmuS and the pOT1 vector were mobilized into E. meliloti 1021 parental and rirA mutant strains by triparental mating in order to generate Sm1021 (pOTprhmuS), Sm1021-TR2 (pOT-prhmuS) and Sm1021-TR2 (pOT1) strains. Plasmid presence in the Sm r and Gm r obtained colonies was confirmed by PCR. Previously constructed Sm1021 (pOT1) (Platero et al. 2004 ) was used as negative control. Cells were grown until midexponential phase in M9S medium and diluted 100-fold in M9S medium supplemented with either 300 lM EDDHA, 300 lM EDDHA plus 1 lM Hm, 300 lM EDDHA plus 20 lM Hm or 37 lM FeCl 3 . Expression of the green fluorescent protein (GFP-UV) was evaluated in a Varioskan Flash Ò (Thermo) using a 405 nm excitation filter and 505 nm emission filter. Quantitative relative fluorescence (RF) was determined according the method of Allaway et al. (Allaway et al. 2001) expressed as fluorescence emission at 505 nm/ OD 620nm . RF values calculated for hmuS promoter fusions in E. meliloti 1021 parental and rirA mutant strains were normalized to the RF values obtained for control strains Sm1021 (pOT1) and Sm1021-TR2 (pOT1) respectively. Results are the mean of three replicates in the same experiment.
Each experiment was repeated independently three times.
Cloning, overexpression and purification of HmuQ and HmuS
Using pSKhmuQ or pSKhmuS plasmids as template, hmuQ or hmuS open reading frames were amplified by PCR. For hmuQ amplification, primers 5-TCGGATC-CATCTCAACAGGCCTGAG-3 and 5-GCAATTCA-TATGTACTTCGCCATG-3 were used. For hmuS amplification, primers 5 0 -GGGAATTCCATATGAC-GATGACTGAG-3 0 and 5 0 -CGCGGATCCGCCGTT-CATCATCACTT-3 0 were used. Restriction sites included in the primers are underlined. Products obtained were cloned in the NdeI and BamHI sites of pET14b (Novagen) generating plasmids pET14b-HmuQ and pET14b-HmuS. E. coli BL21DE3(pLysS) (Novagen) strain was transformed with each of these plasmids. Overexpression and purification of HmuQ and HmuS recombinant proteins was performed as described by Friedman et al. (Friedman and O'Brian 2004) . Correct overexpression and purification were confirmed by SDS-PAGE. Fractions containing HmuQ protein were equilibrated with 50 mM phosphate buffer, pH 8.0, containing 300 mM NaCl and 10 % (v/v) glycerol. Fractions containing HmuS protein were equilibrated with 100 mM phosphate buffer, pH 8.0, and 10 % (v/v) glycerol. Aliquots of 10 lM solution of proteins were stored at -80°C for further use.
Heme binding and heme degradation assays
Heme binding and heme degradation assays were performed as detailed elsewhere (Puri and O'Brian 2006) . To determine the stoichiometry of heme binding to HmuQ or HmuS, spectra were recorded after each heme addition. Absorption at 413 nm was plotted versus the heme concentration.
Heme degradation was determined spectrophotometrically as the decrease in the heme absorbance in the presence of the protein and either ascorbate or human NADPH-cytochrome P450 reductase (Calbiochem) as reductant. A heme degradation control without enzyme in similar conditions was also performed.
Detection of biliverdin as HmuQ or HmuS reaction products
Heme degradation reactions were made as mentioned above. A mixture without HmuQ/HmuS protein was used as a negative control to monitor heme degradation without enzymes (Hm control). Product extraction and HPLC-MS analysis were performed as described by Puri et al. (Puri and O'Brian 2006) .
Detection of dimethyl-esterified biliverdin isomers as HmuQ or HmuS reaction products
Product extraction and esterification was performed as described elsewhere (Wang et al. 2004 ). Dimethylesterified HmuQ and HmuS products were dissolved in CH 2 Cl 2 and subsequently diluted in 0.1 % (v/v) formic acid in acetonitrile, 1/2 and 1/20 respectively. Samples were loaded in a C 18 phenomenex luna analytical HPLC column and a 1 ml/min flow of 0.1 % (v/v) formic acid in acetonitrile was applied. The gradient of acetonitrile (v/v) used was: 30 % acetonitrile 5 min, from 30 to 80 % 35 min, from 80 to 95 % 5 min, 95 % 5 min, from 95 to 30 % 5 min and maintained at 30 % during 5 min.
Dimethyl-esterified biliverdin isomers of the IX series, obtained as previously described (Bonnett and McDonagh 1973) , were suspended in 0.1 % (v/v) formic acid in acetonitrile and used as a standards.
Results
In silico studies
We have previously shown that heme is used as an iron source by E. meliloti 1021 and that the ShmR outer membrane protein is required for heme transport (Amarelle et al. 2008; Battistoni et al. 2002; Noya et al. 1997 ). Here, we wanted to identify HO-encoding genes in E. meliloti in order to evaluate their roles in iron release from the tetrapyrrole ring. The analysis of E. meliloti 1021 genome revealed no canonical HOs in its genome, although two putative genes encoding heme degrading enzymes, smc01518 and hmuS, were identified. SMc01518 showed sequence similarity to the ABM group of enzymes to which IsdG-family of monooxygenases belong. The SMc01518 predicted protein has 50 and 59 % sequence identity (SI) with B.
japonicum HmuD and HmuQ, respectively, and 35 % SI with S. aureus IsdG with only 42 % of coverage. Based on this homology and on data described below, we renamed smc01518 as hmuQ.
The hmuS gene is annotated as a putative gene encoding a hemin transport protein in the E. meliloti genome. It is clustered together with genes involved in heme, Ferrichrome and Ferrioxamine B transport (hmuTUV) and in the regulation of shmR expression (hmuP) (Fig. S1) (Amarelle et al. 2010; Cuiv et al. 2008) . The HmuS amino acid predicted sequence has a 45 % SI with PhuS of P. aeruginosa and 37 % SI with both ChuS of E. coli and HemS of Yersinia enterocolitica. These orthologs of E. meliloti HmuS have been reported to be involved in heme metabolism, either acting as a heme-degrading enzyme or as a heme chaperone and heme oxygenase titratable regulator of heme uptake (Lee et al. 2014; O'Neill and Wilks 2013; Stojiljkovic and Hantke 1994; Suits et al. 2005) . Thus, we decided to characterize hmuQ and hmuS of E. meliloti in order to assess their roles in heme degradation.
HmuQ and HmuS bind one heme per molecule and catalyze heme degradation
Recombinant E. meliloti HmuQ and HmuS were overexpressed in E. coli as N-terminal His 6 -tag fusion proteins and purified by affinity chromatography. Both proteins migrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis according to their calculated molecular masses as his 6 -tag fusions, 13,924 Da for HmuQ and 41,441 Da for HmuS (Fig. S2) . Heme binding capability of 10 lM HmuQ and 10 lM HmuS was assessed spectrophotometrically (Fig. 1a, b respectively) . Both proteins displayed a Soret peak at 413 nm. When proteins were titrated with increasing amounts of heme, the Soret peak absorbance increased, showing an inflection point at 10 lM hemin (Fig. 1a, b, insets) . The data indicate a single site of heme binding for each one of the proteins. Spectroscopic analyses indicate that HmuQ has a K d of 5.1 ± 1.2 lM and HmuS a K d of 4.4 ± 0.7 lM.
With the aim at determining heme degradation activity of HmuQ and HmuS, a single turnover assay was performed in the presence of catalase. Catalase is required to avoid the possible molecular oxygenmediated couple oxidation of heme in the presence of free H 2 O 2 (Sigman et al. 2001) . As the in vivo electron donor of bacterial heme oxygenases is not known and, taking into account previous works on bacterial heme oxygenases (Frankenberg-Dinkel 2004; Puri and O'Brian 2006; Unno et al. 2007; Zhu et al. 2000) , ascorbate or NADPH-cytochrome P450 reductase were used as reductants in the in vitro assays. Analysis of HmuQ-heme and HmuS-heme complexes in the presence of ascorbic acid showed a decrease in the Soret peak at 409 nm as a function of time as expected for a heme-degrading enzyme. As shown in Fig. 2a, b , HmuS-heme degradation was faster than HmuQ-heme degradation while heme in the absence of enzymes showed no significant spectral change during the time of the assay (Fig. S3) . HmuQ-heme and HmuS-heme complexes were also incubated with NADPH-cytochrome P450 reductase, and in these assays, degradation of heme was monitored spectrophotometrically with the addition of 10 lM increments of NADPH. A decrease in the Soret peak at 409 nm was also observed; nonetheless, in this condition, no significant differences between HmuQ and HmuS activities were detected (Fig. 2c, d ). An increase in a peak at 340 nm was observed corresponding to absorption of NADPH, presumably because the substrate became depleted and the NADPH was not completely oxidized. Taken together, results presented here clearly show that HmuQ and HmuS proteins catalyze heme degradation in vitro using either ascorbate or NADPH-cytochrome P450 reductase as reductants.
Biliverdin is produced from HmuQ-and HmuScatalyzed heme degradation
The HmuQ and HmuS products were analyzed by HPLC-MS. Commercialized biliverdin IX-a was used as a standard (Fig. 3a) , and a main peak with a retention time (RT) of 6.48-7.85 was identified. A reaction without enzymes was used as a control and biliverdin was not detected in this reaction (Fig. 3b) . Products obtained after HmuQ-catalyzed reaction gave one peak with the same atomic mass as biliverdin (m/z = 583.2) (Fig. 3c ) with a RT of 5.96-6.16. Degradation products of HmuS displayed two peaks with the same atomic mass to biliverdin (Fig. 3d) . These two peaks showed retention times of 6.44-6.64 and 6.05-6.27, demonstrating that HmuS-dependent heme degradation yields two biliverdin isomers. These results indicate that heme degradation products catalyzed by HmuQ and HmuS are biliverdins and suggest that the isomers produced are not biliverdin IX-a. From the relative abundance (RA) of biliverdin isomers obtained, we can conclude that heme degradation catalyzed by HmuS produces 3.3 times more biliverdin than HmuQ when ascorbate was used as reductant.
In order to identify the biliverdin isomers produced by heme degradation by HmuQ and HmuS, the dimethyl esters of biliverdin IX-a, IX-b, IX-c and IX-d, obtained by chemical oxidation of Fe(III)-protoporphyrin IX dimethyl ester, were used as standards for the HPLC analysis (Fig. S4a) . The dimethyl-esterified derivatives of the products obtained from HmuQ and HmuS catalysis were coinjected with each one of the four isomers. The HmuQ The sample and reference cuvettes were titrated with increasing hemin concentrations as described in the text, and the spectrum was recorded after each addition. The sample cuvette also contained 10 lM of either recombinant protein HmuQ or HmuS. Numbers over the spectra indicate increasing amounts of hemin (lM). The arrow indicates an increase in absorption with increasing amounts of added hemin. In the insets, the absorption at 413 nm displayed by each protein in the binding assays was plot against hemin concentrations. Data shown in this figure are from a single experiment representative of at least three independent assays heme degradation product co-eluted with biliverdin IX-d dimethyl ester (Fig. S4b) . The dimethyl-esterified derivatives of the products obtained from the oxidation of heme by HmuS showed two peaks, one of them eluted together with biliverdin IX-b dimethyl ester and the other with biliverdin IX-d dimethyl ester (Fig. S4c) .Thus, these observations demonstrate that heme is oxidized by HmuQ to produce biliverdin IX-d while HmuS catalyzes heme oxidation with the production of two different biliverdin isomers (biliverdin IX-b and biliverdin IX-d).
The expression of hmuQ and hmuS genes respond to iron and hemin
In a previous report, Chao et al. (2004) described hmuPSTUV to be iron regulated in a RirA-dependent manner, which is consistent with the presence of a putative RirA box in the promoter region reported by Rodionov et al. (Rodionov et al. 2006) . Also, the ORFs smc01514, smc01516, smc01517 and hmuQ were reported to have a similar RirA-dependent regulation pattern (Chao et al. 2005) . In order to evaluate the role of hemin in the regulation of hmuQ and hmuS, we compared by qPCR the expression of both genes in cells grown in different conditions of iron and hemin availability. The smc03224 gene encoding 16S rDNA was used as a constitutive control gene. As shown in Fig. 4 , hmuQ and hmuS genes were expressed in iron restricted medium and repressed in iron sufficient conditions. Expression of both genes was inversely correlated with the hemin concentration of growth medium in presence of the free-iron chelator EDDHA. In addition, hmuS gene expression was almost two times higher than hmuQ gene expression in medium with 300 lM EDDHA and 1 lM hemin. To determine if hmuS regulation depends on RirA, a plasmid-borne hmuS-GFP-UV promoter fusion was introduced in the parental and in the rirA mutant strains, and GFP activity was measured (Fig. S5a) . Repression of hmuS by iron or hemin was lost in a rirA mutant background, demonstrating that this repression is mediated by the RirA protein. A similar regulatory pattern was observed for hmuQ (Fig. S5b) . To test the role of HmuQ and HmuS in E. meliloti physiology, we constructed isogenic hmuQ and hmuS mutants (Sm1021-VAQ and Sm1021-VAS, respectively) and an hmuQ, hmuS double mutant (Sm1021-VAQS). Sm1021-VAS and Sm1021-VAQS mutant strains displayed smaller colony sizes than the parental strain and the Sm1021-VAQ mutant strain, when 10 lM hemin was added to the medium (Fig. 5) . In the presence of 50 lM hemin all the strains exhibited smaller colony sizes, indicative of heme toxicity, but the effect was more pronounced in the Sm1021-VAS and Sm1021-VAQS mutant strains, suggesting a role of hmuS in heme detoxification. Taking into account that iron scavenging by the siderophore produced by E. meliloti may interfere with heme-dependent phenotypes, growth experiments were also performed using the Rhizobactin 1021-deficient mutant strain, Sm1021-H38, as a genetic background. The rhrA mutation present in the Sm1021-H38 mutant strain was transduced to the hmuQ, hmuS and hmuQS backgrounds as detailed in materials and methods section, generating mutant strains Sm1021-H38VAQ, Sm1021-H38VAS and Sm1021-H38VAQS. Addition of hemin in the range of 0.5-50 lM clearly improved Sm1021-H38 growth in iron chelated medium (Fig. 6) , with maximal growth observed with 5 lM hemin. The Sm1021-H38VAQ mutant strain, displayed a lower growth than the Sm1021-H38 strain in the range of 1 lM to 30 lM hemin. The Sm1021-H38VAS and the Sm1021-H38VAQS mutants presented a similar growth defect being more pronounced at hemin concentrations in the range of 10-50 lM.
Results obtained here suggest that HmuQ and HmuS participate in heme utilization as an iron source at least when heme is present in the range of 0.5-40 lM. Nonetheless, the triple mutant Sm1021-H38VAQS was still able to grow in iron-chelated medium supplemented with hemin suggesting the presence of a third heme degrading enzyme or of another mechanism involved in iron release from heme.
Moreover, results presented in Fig. 5 together with results shown in Fig. 6 indicate that hemin concentrations higher than 40 lM, impaired bacterial growth of the parental strain (colony size on solid medium and OD 620nm in liquid medium) and that this effect is more pronounced in the hmuS mutant. These observations suggest a role for HmuS in heme detoxification.
Discussion
In this work, we conducted a biochemical and physiological approach to characterize two (Fig. 1 ) a common feature for heme oxygenases, IsdG-like monooxygenases and PhuS homologs. Moreover, HmuQ and HmuS affinities for heme (5 and 4 lM, respectively) were similar to those previously reported for other heme oxygenases (Gisk et al. 2012; Skaar et al. 2004) . Interestingly, we found that heme is oxidized by E. meliloti HmuS to biliverdin IX-b and biliverdin IX-d a characteristic previously reported for HemO (formerly PigA) a heme oxygenase of P. aeruginosa and probably for Vibrio cholerae HutZ (Gisk et al. 2012; Ratliff et al. 2001; Uchida et al. 2012; Wegele et al. 2004 meliloti HmuS, in the presence of ascorbate was very efficient being almost all the heme degraded in few minutes (Fig. 2b) . However, whether HmuS is a heme oxygenase, and/or a heme trafficking protein in vivo, remains to be determined. Concerning HmuQ, its closest homologs belong to the group of the IsdG family of monooxygenases, displaying 59 % SI with the HmuQ from B. japonicum. When ascorbate was used as a reductant, heme degradation by HmuQ was almost ten times slower than HmuS-catalyzed reaction (Fig. 2a, b) . Native reductant for HmuQ activity is not known and perhaps this low performance of HmuQ is due to the fact that ascorbate might not be an appropriate reductant. An alternative explanation could be that HmuQ hemedegrading activity requires a chaperone involved in either heme delivery to HmuQ or in facilitating the dissociation of the degradation product from the protein. The product of heme degradation catalyzed by HmuQ is biliverdin IX-d isomer. This compound has also been reported as the heme-degradation product of HugZ, a novel heme oxygenase from Helicobacter pylori, different from the IsdG family of heme-degrading monooxygenase (Guo et al. 2008; Hu et al. 2011) . The finding that different biliverdin isomers could be obtained as a result of heme degradation, open the question whether these heme metabolites have unique bacterial functions.
In order to determine the conditions required for hmuS and hmuQ expression in vivo, we evaluated their expression under iron sufficient, iron deprived and 
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Sm1021-H38 Sm1021-H38VAQ Sm1021-H38VAS Sm1021-H38VAQS iron deprived medium supplemented with different hemin concentrations. We found that both hmuQ and hmuS genes are repressed by iron and also by hemin. Previously, Rodionov et al. (Rodionov et al. 2006) described the presence of a putative RirA box in the promoter region of hmuPSTUV operon and Chao et al. (Chao et al. 2005 ) demonstrated that hmuSTUV and hmuQ are iron regulated in a RirA dependent manner.
Results presented here are in accordance with these data, and additionally show that hmuS and hmuQ expression is also repressed by heme in a RirA dependent way. It is considered that HOs are able to provide nutritional iron from heme, although this physiological role is difficult to establish because the heme oxygenase mutants usually display a subtle phenotype. Data presented here show that in E. meliloti, growth of hmuS and hmuQ mutants was impaired in iron-limited medium supplemented with hemin as iron source (Fig. 6 ). These data, together with the fact that hmuS and hmuQ genes are maximally expressed under irondeprived conditions (Fig. 4) , suggest that both HmuQ and HmuS proteins are important for the use of heme as iron source under iron-limiting conditions. Finally, we consider the possibility that HmuS and/or HmuQ might also be involved in counteract heme toxicity. We found that hmuS mutant, but not hmuQ mutant, was sensitive to heme concentrations higher than 50 lM (Figs. 5, 6 ) indicating that HmuS participate in avoiding heme toxicity.
